Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen vs Ketorolac for Acute Osteoarticular Trauma Pain in Children
NCT04133623Phase 3Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Nov 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in acute pain (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Pain reduction assessed on the NRS scale. Started Nov 2019; status: completed.
02
Drugs
ketorolac
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04133623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133623.